Developer docs
API playgroundTry for free, no card

Search company profiles

ZoomRx

Full company profile

uuid0005l5o

Namestring
ZoomRx
Legal namestring
ZoomRx Inc.
Websiteurl
zoomrx.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. The company delivers market insights, competitive intelligence, and commercial strategy consulting across the drug lifecycle, backed by a proprietary panel of 60,000+ healthcare professionals and 700M+ benchmark datapoints accumulated over more than 15 years of life sciences domain work. Its stated client base includes 19 of the top 20 global pharmaceutical companies and over 100 leading biopharma organizations, with named customers including Novartis, Johnson & Johnson, Sanofi, AbbVie, Roche, AstraZeneca, Amgen, Gilead, Regeneron, MSD, Biogen, BioNTech, and others.

The company's product portfolio centers on three proprietary AI platforms. Sagan Agents is a continuous intelligence platform with three modules (Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research) that uses autonomous AI agents and conversational interfaces to convert siloed client data into queryable intelligence. Patient Scribe is a voice-first conversational platform for patient chart audits that replaces click-through surveys with natural spoken dialogue, capturing physician reasoning behind treatment decisions. Ferma is an AI market intelligence platform that synthesizes drug pipelines and medical conferences in real time, including a Ferma Congress sub-product for live event coverage. Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Media Tracking, HCP-Patient Conversations, and commercial consulting for launch excellence and decision sciences. The underlying technology stack combines natural language processing, speech and audio processing, generative AI, autonomous agents, knowledge retrieval, predictive analytics, and process automation across text, audio, and multimodal inputs.

ZoomRx monetizes through a hybrid revenue model combining professional services and recurring subscriptions. Custom consulting engagements are priced at six figures per project, while the Sagan Agents platform is offered as an annual subscription with flexible pricing tied to the number of brands and modules deployed. A free Data Archive ingestion pilot is bundled with existing client engagements to lower switching friction. Distribution is entirely direct enterprise sales to pharmaceutical decision-makers with no third-party channel partners disclosed. The company is privately held and founder-led by Co-CEO and Co-Founder Sriram Subramanian, with no disclosed external funding rounds; it operates from a U.S. corporate entity (ZoomRx Inc.) while maintaining operational presence in Chennai, India.

Short descriptiontext

ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. It combines proprietary AI platforms (Sagan Agents, Ferma, Patient Scribe) with a 60,000+ HCP panel and 700M+ benchmark datapoints to deliver market insights across the drug lifecycle.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical market research, life sciences consulting, pharma market insights, healthcare analytics, HCP market research
NAICS code3 codes
  • Marketing Research and Public Opinion Polling541910
  • Management Consulting Services54161
  • Software Publishers51321
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Research & Life Sciences Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Life Sciences Consulting
TypeProfessional Services
Description

Strategic consulting engagements for pharmaceutical companies covering launch excellence, market and competitive intelligence, patient insights, and commercial strategy. Revenue generated through project-based consulting engagements with enterprise pharma clients.

zoomrx.com
2Sagan Agents Platform Subscription
TypeSubscription Recurring
Description

AI-powered continuous intelligence platform offered as subscription with flexible pricing. Includes Data Archive pilot bundled with existing projects, and full platform pricing customized based on number of brands and modules. Delivers answers in hours instead of weeks, replacing costly one-off projects.

zoomrx.com
3Market Research Tracking Studies
TypeSubscription Recurring
Description

Primary market research tracking studies including Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, and HCP-Patient Conversations. Continuous pharma insights form the intelligence backbone of successful biopharma commercialization.

zoomrx.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Pricing details3 tiers
1Data Archive pilot bundled with existing engagements
ModelSubscriptionBilling cadenceAnnual
Notes

Free Data Archive ingestion pilot available for existing ZoomRx clients, with data formats already understood and platform live within weeks of kickoff.

zoomrx.com
2Full Sagan Agents platform
ModelSubscriptionBilling cadenceAnnual
Notes

Full platform pricing customized based on number of brands and modules. Flexible pricing available. Dramatic savings through elimination of redundant projects, compression of timelines, and simulation that replaces costly live studies.

zoomrx.com
3Custom consulting and research engagements
ModelOtherBilling cadenceMulti-year contract
Notes

Six figures per project for traditional consulting engagements, with costs compounding across redundant engagements. ZoomRx positions Sagan Agents as replacing costly one-off projects.

zoomrx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Sagan Agents
Description

AI-powered continuous intelligence platform for life sciences that converts siloed data into an always-on operating system

zoomrx.com
+5 more records
Core offering1 text field

ZoomRx delivers AI-powered market research and life sciences consulting to pharmaceutical companies through proprietary platforms (Sagan Agents, Ferma, Patient Scribe) that combine conversational AI with proprietary HCP/patient panels spanning 60,000+ healthcare professionals and 700M+ benchmark datapoints. The firm provides tracking studies (promotional, brand, chart audits, media, HCP-patient conversations) and strategic consulting (launch excellence, commercial analytics, competitive intelligence) covering the full drug lifecycle.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

ZoomRx is a strategic life sciences consulting firm offering an integrated platform-plus-modules architecture. The core offering combines proprietary AI technology (Sagan Agents platform) with deep therapeutic expertise and proprietary data assets (60K+ HCP panel, 700M+ benchmark datapoints). The main products include: Sagan Agents (continuous intelligence platform with Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research modules); Ferma (AI market intelligence with Ferma Congress and Ferma Agents); Patient Scribe (conversational chart audit platform); and Sagan (conversational survey platform). Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, HCP-Patient Conversations, Launch Excellence consulting, and Commercial Consulting Analytics. The portfolio integrates primary research with secondary data to deliver AI-powered pharma insights across the drug lifecycle.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1ZS Associates
TypeBroad incumbent
Description

ZS Associates is a large management consulting and technology firm specializing in pharma and healthcare, with deep capabilities in commercial analytics, AI-driven sales force effectiveness, and market research. It overlaps with ZoomRx but serves a much broader portfolio of pharma services.

TypeDirect peer
Description

IQVIA is the largest global provider of pharma market research, commercial analytics, and real-world evidence. It directly competes with ZoomRx in pharma insights, brand tracking, and commercial strategy, with significantly broader data assets and enterprise reach.

TypeDirect peer
Description

Definitive Healthcare is a healthcare commercial intelligence platform serving pharma and biotech with provider data, claims analytics, and market insights. It competes with ZoomRx in commercial intelligence and HCP/patient data layers serving pharma commercial teams.

TypeDirect peer
Description

Citeline (formerly Pharma Intelligence, part of Informa) provides pharma pipeline intelligence, clinical trial analytics, and commercial insights. It directly competes with ZoomRx's Ferma platform for drug pipeline and competitive intelligence workflows.

5Ipsos Healthcare
TypeDirect peer
Description

Ipsos Healthcare is the global pharma and healthcare research arm of Ipsos, offering market research, brand tracking, and HCP/patient insights. It is a direct peer for ZoomRx's market research and tracking-study business lines.

TypeDirect peer
Description

GlobalData provides pharma market research, competitive intelligence, and industry analytics to biopharma. It competes with ZoomRx's market and competitive intelligence solutions, particularly in drug pipeline tracking and therapy-area insights.

TypeDirect peer
Description

EVERSANA is a commercial pharma services provider covering market access, patient services, and commercial analytics. It overlaps with ZoomRx in commercial strategy, market access, and life sciences insights for global biopharma clients.

TypeDirect peer
Description

Trinity Life Sciences is a life sciences strategy consulting and market research firm offering commercial analytics, brand tracking, and competitive intelligence to global pharma. It is one of ZoomRx's closest direct peers in the strategic consulting + insights hybrid model.

TypeDirect peer
Description

Kantar's Health division delivers market research and insights for pharma and consumer health, including brand tracking and HCP research. It is a direct peer for ZoomRx's brand tracking (ATU), promotional effectiveness, and HCP research offerings.

TypeDirect peer
Description

Clarivate provides pharma intelligence, drug pipeline data, and commercial analytics (formerly Thomson Reuters Pharma). It directly competes with ZoomRx's Ferma platform for drug pipeline, competitive intelligence, and biopharma commercial decision support.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ZoomRx

Pharmaceutical Market Research & Life Sciences Consultingzoomrx.com

ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. It combines proprietary AI platforms (Sagan Agents, Ferma, Patient Scribe) with a 60,000+ HCP panel and 700M+ benchmark datapoints to deliver market insights across the drug lifecycle.

What ZoomRx does

ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. The company delivers market insights, competitive intelligence, and commercial strategy consulting across the drug lifecycle, backed by a proprietary panel of 60,000+ healthcare professionals and 700M+ benchmark datapoints accumulated over more than 15 years of life sciences domain work. Its stated client base includes 19 of the top 20 global pharmaceutical companies and over 100 leading biopharma organizations, with named customers including Novartis, Johnson & Johnson, Sanofi, AbbVie, Roche, AstraZeneca, Amgen, Gilead, Regeneron, MSD, Biogen, BioNTech, and others.

The company's product portfolio centers on three proprietary AI platforms. Sagan Agents is a continuous intelligence platform with three modules (Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research) that uses autonomous AI agents and conversational interfaces to convert siloed client data into queryable intelligence. Patient Scribe is a voice-first conversational platform for patient chart audits that replaces click-through surveys with natural spoken dialogue, capturing physician reasoning behind treatment decisions. Ferma is an AI market intelligence platform that synthesizes drug pipelines and medical conferences in real time, including a Ferma Congress sub-product for live event coverage. Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Media Tracking, HCP-Patient Conversations, and commercial consulting for launch excellence and decision sciences. The underlying technology stack combines natural language processing, speech and audio processing, generative AI, autonomous agents, knowledge retrieval, predictive analytics, and process automation across text, audio, and multimodal inputs.

ZoomRx monetizes through a hybrid revenue model combining professional services and recurring subscriptions. Custom consulting engagements are priced at six figures per project, while the Sagan Agents platform is offered as an annual subscription with flexible pricing tied to the number of brands and modules deployed. A free Data Archive ingestion pilot is bundled with existing client engagements to lower switching friction. Distribution is entirely direct enterprise sales to pharmaceutical decision-makers with no third-party channel partners disclosed. The company is privately held and founder-led by Co-CEO and Co-Founder Sriram Subramanian, with no disclosed external funding rounds; it operates from a U.S. corporate entity (ZoomRx Inc.) while maintaining operational presence in Chennai, India.

ZoomRx firmographics

Firmographics
Name
ZoomRx
Legal name
ZoomRx Inc.
Website
https://zoomrx.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
501–1,000 employees
Short description
ZoomRx is a strategic life sciences consulting firm and AI-powered market research company serving global pharmaceutical and biotechnology companies. It combines proprietary AI platforms (Sagan Agents, Ferma, Patient Scribe) with a 60,000+ HCP panel and 700M+ benchmark datapoints to deliver market insights across the drug lifecycle.
Ownership category
akta.pro rank

Where ZoomRx is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

ZoomRx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. Life Sciences Consulting: Strategic consulting engagements for pharmaceutical companies covering launch excellence, market and competitive intelligence, patient insights, and commercial strategy. Revenue generated through project-based consulting engagements with enterprise pharma clients.
  2. Sagan Agents Platform Subscription: AI-powered continuous intelligence platform offered as subscription with flexible pricing. Includes Data Archive pilot bundled with existing projects, and full platform pricing customized based on number of brands and modules. Delivers answers in hours instead of weeks, replacing costly one-off projects.
  3. Market Research Tracking Studies: Primary market research tracking studies including Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, and HCP-Patient Conversations. Continuous pharma insights form the intelligence backbone of successful biopharma commercialization.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualData Archive pilot bundled with existing engagements
SubscriptionAnnualFull Sagan Agents platform
OtherMulti-year contractCustom consulting and research engagements

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

ZoomRx product offering

Product offering

Core offering

ZoomRx delivers AI-powered market research and life sciences consulting to pharmaceutical companies through proprietary platforms (Sagan Agents, Ferma, Patient Scribe) that combine conversational AI with proprietary HCP/patient panels spanning 60,000+ healthcare professionals and 700M+ benchmark datapoints. The firm provides tracking studies (promotional, brand, chart audits, media, HCP-patient conversations) and strategic consulting (launch excellence, commercial analytics, competitive intelligence) covering the full drug lifecycle.

Product overview

ZoomRx is a strategic life sciences consulting firm offering an integrated platform-plus-modules architecture. The core offering combines proprietary AI technology (Sagan Agents platform) with deep therapeutic expertise and proprietary data assets (60K+ HCP panel, 700M+ benchmark datapoints). The main products include: Sagan Agents (continuous intelligence platform with Strategic Insights Agents, Data Archive Intelligence, and Agentic Market Research modules); Ferma (AI market intelligence with Ferma Congress and Ferma Agents); Patient Scribe (conversational chart audit platform); and Sagan (conversational survey platform). Supporting services include Promotional Effectiveness Tracking (PET), Brand Tracking (ATU), Patient Chart Audits (PCA), Media Tracking, HCP-Patient Conversations, Launch Excellence consulting, and Commercial Consulting Analytics. The portfolio integrates primary research with secondary data to deliver AI-powered pharma insights across the drug lifecycle.

Differentiator

Problem solved

Functional benefit

Brands

  • Sagan Agents: AI-powered continuous intelligence platform for life sciences that converts siloed data into an always-on operating system
  • Sagan
  • Ferma
  • Ferma Congress
  • Patient Scribe
  • Curie

Companies that use ZoomRx

Customer profile

Named customers19 records

Segments4 records

Ideal customer profiles1 record

ZoomRx technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature6 records

ZoomRx partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

ZoomRx competitors and assessment

Company assessment

Broad incumbents

  • ZS Associates: ZS Associates is a large management consulting and technology firm specializing in pharma and healthcare, with deep capabilities in commercial analytics, AI-driven sales force effectiveness, and market research. It overlaps with ZoomRx but serves a much broader portfolio of pharma services.

Direct peers

  • IQVIA: IQVIA is the largest global provider of pharma market research, commercial analytics, and real-world evidence. It directly competes with ZoomRx in pharma insights, brand tracking, and commercial strategy, with significantly broader data assets and enterprise reach.
  • Definitive Healthcare: Definitive Healthcare is a healthcare commercial intelligence platform serving pharma and biotech with provider data, claims analytics, and market insights. It competes with ZoomRx in commercial intelligence and HCP/patient data layers serving pharma commercial teams.
  • Informa Pharma Intelligence (Citeline): Citeline (formerly Pharma Intelligence, part of Informa) provides pharma pipeline intelligence, clinical trial analytics, and commercial insights. It directly competes with ZoomRx's Ferma platform for drug pipeline and competitive intelligence workflows.
  • Ipsos Healthcare: Ipsos Healthcare is the global pharma and healthcare research arm of Ipsos, offering market research, brand tracking, and HCP/patient insights. It is a direct peer for ZoomRx's market research and tracking-study business lines.
  • GlobalData: GlobalData provides pharma market research, competitive intelligence, and industry analytics to biopharma. It competes with ZoomRx's market and competitive intelligence solutions, particularly in drug pipeline tracking and therapy-area insights.
  • EVERSANA: EVERSANA is a commercial pharma services provider covering market access, patient services, and commercial analytics. It overlaps with ZoomRx in commercial strategy, market access, and life sciences insights for global biopharma clients.
  • Trinity Life Sciences: Trinity Life Sciences is a life sciences strategy consulting and market research firm offering commercial analytics, brand tracking, and competitive intelligence to global pharma. It is one of ZoomRx's closest direct peers in the strategic consulting + insights hybrid model.
  • Kantar (Health division): Kantar's Health division delivers market research and insights for pharma and consumer health, including brand tracking and HCP research. It is a direct peer for ZoomRx's brand tracking (ATU), promotional effectiveness, and HCP research offerings.
  • Clarivate: Clarivate provides pharma intelligence, drug pipeline data, and commercial analytics (formerly Thomson Reuters Pharma). It directly competes with ZoomRx's Ferma platform for drug pipeline, competitive intelligence, and biopharma commercial decision support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

ZoomRx social profiles

Digital presence

ZoomRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ZoomRx leadership team

Management profile

Number of profiles

Profiles1 record

ZoomRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ZoomRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ZoomRx

What does ZoomRx do?

ZoomRx delivers AI-powered market research and life sciences consulting to pharmaceutical companies through proprietary platforms (Sagan Agents, Ferma, Patient Scribe) that combine conversational AI with proprietary HCP/patient panels spanning 60,000+ healthcare professionals and 700M+ benchmark datapoints. The firm provides tracking studies (promotional, brand, chart audits, media, HCP-patient conversations) and strategic consulting (launch excellence, commercial analytics, competitive intelligence) covering the full drug lifecycle.

Is ZoomRx a public or private company?

ZoomRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ZoomRx founded?

ZoomRx was founded in 2010. It employs 501 to 1,000 people.

Where is ZoomRx based?

ZoomRx is headquartered in Cambridge, United States, in the North America region.

How does ZoomRx make money?

Three revenue lines are on record. Life Sciences Consulting is the primary driver. The others are sagan Agents Platform Subscription and market Research Tracking Studies.

Who are ZoomRx's main competitors?

ZS Associates is listed as a broad incumbent. Direct peers are IQVIA, Definitive Healthcare, Informa Pharma Intelligence (Citeline), Ipsos Healthcare, GlobalData, EVERSANA, Trinity Life Sciences, Kantar (Health division) and Clarivate.

Does ZoomRx have an API?

Yes. Sagan Agents supports bring-your-own API key (BYOK) deployment, suggesting an API exists for client integration. The platform mentions SSO integration, role-based access controls, and audit logging. Specific API documentation URL was not provided in the source material.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireZoomRx Launches Signal-IQ: Competitive Field Intelligence, Delivering Real-Time NPI-Level Visibility into Competitor Sales Force Activity for Pharma Commercial TeamsZoomRx, a strategic life sciences consultancy trusted by over 100 leading biopharma companies, announced the launch of Signal-IQ: Competitive Field Intelligence, a proprietary tool providing pharma commercial teams with near-real-time, NPI-level visibility into competitor sales force activity targeting healthcare professionals. The solution uses proprietary algorithms that transform anonymized cell phone mobility signals into validated commercial intelligence, offering weekly or bi-weekly updates with an 85%+ match rate against client call data, addressing the gap where CMS Open Payments data is 6 to 18 months delayed. Signal-IQ is available to pharma and biotech organizations as a pilot program and integrates with existing CRM workflows for pre-call planning and promotional evaluation.ZoomrxEffective Pharmaceutical Brand Positioning: ZoomRx's Strategic ApproachZoomRx published a blog post outlining common pitfalls in pharmaceutical brand positioning research, including testing too few or too many concepts, treating selection as a popularity contest, and relying only on rational criteria. The firm proposes success criteria of uniqueness, relevance, believability and motivation, plus seven best practices, and invites readers to contact Dan Callahan for more information.GlobeNewswireZoomRx Announces Launch of ZoomRx TV Tracking: The First TV Media Measurement and Optimization Platform Designed for Life SciencesZoomRx launched ZoomRx TV Tracking, a platform that measures individual-level TV viewing and ad exposure across linear and streaming channels using verified patient panels. It links ad exposure to behavioral outcomes and multi-screen activity, enabling benchmarking against competitors. The launch expands ZoomRx's one-stop shop for evaluating field force, digital, and TV campaigns.GlobeNewswireZoomRx Launches the Ferma Engine: Revolutionizing Custom AI Solutions for Pharma & BiotechZoomRx launched the Ferma Engine, a platform for pharma and biotech professionals to build custom generative AI solutions. The platform emphasizes data integrity, customization, and life sciences context, and is now available for partnerships and pilot projects.GlobeNewswireZoomRx Launches the Ferma Engine: Revolutionizing Custom AI Solutions for Pharma & BiotechZoomRx launched the Ferma Engine, a platform for pharma and biotech professionals to build custom generative AI solutions. The platform emphasizes data integrity, customization, and life sciences context, and is now available for partnerships and pilot projects.GlobeNewswireZoomRx Announces Launch of Ferma: The First AI-Powered Ally Uniquely Crafted to Empower Life Sciences ProfessionalsZoomRx launched Ferma, an AI-powered conversational platform for life sciences professionals, on May 22, 2023. The platform provides accurate, cited answers from over 4 million publications and 190,000 clinical trials, with tiered pricing starting at $100 per month for Pro.